Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 May 1;24(Suppl 2):e106-e115.
doi: 10.2459/JCM.0000000000001431.

Artificial intelligence in cardiovascular prevention: new ways will open new doors

Affiliations
Review

Artificial intelligence in cardiovascular prevention: new ways will open new doors

Michele Ciccarelli et al. J Cardiovasc Med (Hagerstown). .

Abstract

Prevention and effective treatment of cardiovascular disease are progressive issues that grow in tandem with the average age of the world population. Over recent decades, the potential role of artificial intelligence in cardiovascular medicine has been increasingly recognized because of the incredible amount of real-world data (RWD) regarding patient health status and healthcare delivery that can be collated from a variety of sources wherein patient information is routinely collected, including patient registries, clinical case reports, reimbursement claims and billing reports, medical devices, and electronic health records. Like any other (health) data, RWD can be analysed in accordance with high-quality research methods, and its analysis can deliver valuable patient-centric insights complementing the information obtained from conventional clinical trials. Artificial intelligence application on RWD has the potential to detect a patient's health trajectory leading to personalized medicine and tailored treatment. This article reviews the benefits of artificial intelligence in cardiovascular prevention and management, focusing on diagnostic and therapeutic improvements without neglecting the limitations of this new scientific approach.

PubMed Disclaimer

References

    1. Boccanelli A, Botta G. New prevention scenarios: polygenic risk. Eur Heart J Suppl 2021; 23: (Suppl E): E33–E35.
    1. Visseren FLJ, Mach F, Smulders YM, et al. ESC National Cardiac Societies, ESC Scientific Document Group. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2021; 42:3227–3337.
    1. Frary CE, Blicher MK, Olesen TB, et al. Circulating biomarkers for long-term cardiovascular risk stratification in apparently healthy individuals from the MONICA 10 cohort. Eur J Prev Cardiol 2020; 27:570–578.
    1. Faggiano P, Dasseni N, Gaibazzi N, Rossi A, Henein M, Pressman G. Cardiac calcification as a marker of subclinical atherosclerosis and predictor of cardiovascular events: a review of the evidence. Eur J Prev Cardiol 2019; 26:1191–1204.
    1. Kozakova M, Palombo C. Imaging subclinical atherosclerosis in cardiovascular risk stratification. Eur J Prev Cardiol 2020; 98:177–184.

Substances

LinkOut - more resources